Barclays has reiterated its Underweight rating on Allstate while increasing its price target. Despite the higher price target, it still implies a significant downside, suggesting continued caution from the analyst firm regarding the stock's future performance.
Barclays maintained its 'Underweight' rating on The Allstate Corporation, indicating a continued bearish outlook on the stock. While the price target was raised from $221 to $228, this new target still implies a potential downside of approximately 15.3% from the stock's closing price on November 4, 2026. This action suggests that despite a slightly improved valuation perspective, Barclays still believes Allstate will underperform. For traders, this reinforces a cautious stance on Allstate, potentially leading to short-term selling pressure or a lack of buying interest, as the long-term outlook from this analyst remains negative.